NA
OCEA

Nordwand Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Nordwand Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,000
Closed -$1.96K – 143
2024
Q3 		$1.96K Buy
+2,000
New +$2.14K ﹤0.01% 123

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Nordwand Advisors's OCEA Position: Q4 2024 in Review

Nordwand Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q4 2024, closing a stake of 2,000 shares — an estimated $1.96K sold.

Nordwand Advisors first reported a position in OCEA in Q3 2024 and held it in 1 quarter. The position peaked at $1.96K in Q3 2024. 22 funds tracked by Wall St. Rank hold OCEA as of Q4 2024.

  • Nordwand Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Nordwand Advisors sold 2,000 Ocean Biomedical, Inc. Common Stock shares in Q4 2024, an estimated $1.96K.
  • Nordwand Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Nordwand Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $1.96K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q4 2024.

Based on Nordwand Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.